Comment: Pancreatic cancer survival extended by over a year with chemotherapy regimen
Dr Andrew Epstein and Prof Richard Schilsky comment on data, during a press conference at the 2018 American Society of Clinical Oncology (ASCO) Annual ...
ecancer
Debate: Optimal neoadjuvant stategy in pancreatic cancer? - Pre-operative Chemotherapy + Radiation
In this presentation from the Great Debates in Gastrointestinal Malignancies 2018 conference, Dr. Michael Choti argues in favor of the use of pre-operative ...
ImedexCME
Clinical consultation skills: Communication and optimal cancer care
Effective clinician communication skills are well recognised as beneficial for both patients and clinicians. Evidence demonstrates that appropriate, timely and ...
Cancer Council Victoria
Discussion on Clinical Trial Endpoints
Discussion on Clinical Trial Endpoints with Barry Goldspiel talking about FDA approval considerations, new endpoints, metastasis-free survival for the Principles ...
NIH Clinical Center
Debate: Optimal therapy for patients with resectable pancreatic cancer - Surgery plus adjuvant chemo
In this presentation from the ESMO 20th World Congress on Gastrointestinal Cancer, Dr. Pascal Hammel argues in favor of surgery plus adjuvant chemotherapy ...
ImedexCME
Colon Cancer Update | Rimma Shaposhnikov, MD, Natalie Manitius, MPH, RDN, UCLA Gastroenterology
Rimma Shaposhnikov, MD UCLA gastroenterologist and Natalie Manitius, MPH, RDN, UCLA GI Dietitian, discuss which screening modalities work for colon ...
UCLA Health
"PCNSL - WBRT versus Intensive Chemotherapy with Hematopoietic Stem Cell Rescue
Lymphoma Hub
Debate: Optimal therapy for patients with resectable pancreatic cancer - Neoadjuvant chemotherapy
In this presentation from the ESMO 20th World Congress on Gastrointestinal Cancer, Dr. Jordan D. Berlin argues in favor of the use of neoadjuvant ...
ImedexCME
Annalisa Chiappella, EHA 2018 – TP53 mutations in DLBCL: the FIL-DLCL04 study
Annalisa Chiapella from Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino in Italy talks to touchONCOLOGY about patients with ...
Touch Medical Media Services
For Older AML Patients, Venetoclax With Low-Dose Cytarabine is Safe and “Promising”
Tara L. Lin, MD, shares the initial findings from a trial evaluating venetoclax with standard low-dose cytarabine in older patients with acute myeloid leukemia who ...
American Society of Hematology
Adjuvant treatment in gastric cancer: The US view
This Congress is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to ...
ImedexCME
New Options for Gastrointestinal Cancer Therapies
Dr. George A. Fisher, a Stanford Cancer Institute researcher and oncologist, discussed clinical research on gastrointestinal cancer therapies with a focus on ...
Stanford Health Care
Stanford Doctors on Latest Advances in Lung Cancer Screening and Treatment
Lung cancer is the leading cause of cancer death in both men and women. This talk will address new lung cancer screening guidelines for former heavy ...
Stanford Health Care
Are We Ready to De-Escalate? Treatment of HPV+ Head and Neck Cancer
A Department of Medicine Grand Rounds presented by Krzysztof Misiukiewicz, MD, Associate Professor of Medicine (Hematology and Medical Oncology) and ...
Icahn School of Medicine
Debate: Best second line therapy for relapsed Hodgkin lymphoma - Brentuximab alone/+ chemo
In this presentation from the 2017 Great Debates & Updates in Hematologic Malignancies, Dr. Ann S. LaCasce argues that the best pre-transplant second line ...
ImedexCME
SCCHN: Chemotherapy for Advanced Disease. Where Are We? - Kies
Recorded at the 19th Annual Meeting of the Network of Oncology Clinicians and Researchers (NOCR) 2013. Earn CME at: http://elc.imedex.com.
ImedexCME
General Principles of Head & Neck Cancer Management - Dr. Brian O'Sullivan
General Principles of Head & Neck Cancer Management Dr. Brian O'Sullivan MD The Princess Margaret Cancer Centre, Toronto, Canada To approach H&N ...
Accelerated Education Program (AEP)
Virginia Polky discusses facing advanced lung cancer after refusing chemotherapy
Virginia Polkey came in to give her account of lung cancer, which was diagnosed in 2012. She discusses the diagnosis and surgery (including side effects), and ...
MyCancerStory
Understanding Your Risk of Developing a Second Cancer
NYU Langone oncologist Dr. Marlene Meyers speaks about risk factors that are associated with a second cancer and strategies to reduce a recurrence.
NYU Langone Health
Improving the outcome of patients with metastatic pancreatic cancer
In this presentation from the ESMO 19th World Congress on Gastrointestinal Cancer, Dr. Thomas Seufferlein discusses strategies for improving the outcomes of ...
ImedexCME
Nutrition and Colorectal Cancer
Dietician and Assistant Director for the Food and Nutrition Services Program at The Alliance For Positive Change, Josephine Ledda discusses the importance of ...
NYU Langone Health
How to Manage Depression and Anxiety After Cancer Treatment - Dana-Farber Cancer Institute
Feeling sad, lonely, or irritable after cancer treatment is common, but these feelings can become a problem if they interfere with daily life, says Karen Fasciano, ...
Dana-Farber Cancer Institute
Public Lecture: Immunotherapy & Cancer - The latest research
Our own immune system can help fight cancer. Drs Douglas Fearon (CSHL) and Robert Maki (Northwell Health) talk about the latest science and how ...
Cold Spring Harbor Laboratory
FLOT4: Perioperative Strategies in Gastroesophageal Cancer
Panelists Johanna C. Bendell, MD; Ian Chau, MD; and Manish A. Shah, MD, review the results from the FLOT4 study in the perioperative setting of ...
OncLiveTV
A new era of treatment for elderly acute myeloid leukemia (AML) patients?
Hagop M. Kantarjian, MD of MD Anderson Cancer Center, Houston, TX discusses the new era of treatment for elderly acute myeloid leukemia (AML) patients at ...
VJHemOnc – Video Journal of Hematological Oncology
Onco-Anesthesiology: Caring for the Cancer Surgery Patient
At the IARS 2019 Annual Meeting, Dr. Vijaya Gottumukkala, from the University of Texas MD Anderson Cancer Center, presents the symposium - The Evolution ...
International Anesthesia Research Society
Evaluating and Treating Cancer Pain | Memorial Sloan Kettering
Cancer pain is a multidimensional phenomenon that can be caused or heightened by many things, including the disease itself, treatments such as ...
Memorial Sloan Kettering
Innovations in Breast Cancer Research
Dr. Keith Knutson discusses advances in breast cancer research, particularly the breast cancer vaccine he is developing. Hear from other experts at the 2019 ...
Mayo Clinic
Adult Brain and Spine Tumor Research and Treatment
Chief, Dr. Mark Gilbert and Senior Investigator, Dr. Terri Armstrong, of the NCI Center for Cancer Research, Neuro-Oncology Branch, will be joined by moderator ...
National Cancer Institute
Metastatic Pancreatic Cancer: Treatment Approaches
John L. Marshall, MD; Eileen M. O'Reilly, MD; George P. Kim, MD; Kabir Mody, MD; and Tanios S. Bekaii-Saab, MD, describe their personal approaches to ...
OncLiveTV
Ovarian Cancer: Selecting an Appropriate PARP Inhibitor
Matthew Powell, MD; Whitney S. Graybill, MD, MS; and Oliver Dorigo, MD, PhD, offer considerations for deciding what PARP inhibitor to use while treating a ...
OncLiveTV
Consolidation Chemotherapy in AML
The use of liposomal cytarabine/daunorubicin followed by consolidation therapy in secondary AML was associated with more patients receiving transplant and ...
Targeted Oncology
Debate: Optimal adjuvant therapy for resected pancreatic cancer? - Gem/Nab-Paclitaxel or FOLFIRINOX
In this presentation from the Great Debates in Gastrointestinal Malignancies 2018 conference, Dr. Jordan Berlin argues in favor of either ...
ImedexCME
High risk HPV Induced Oropharyngeal Cancer Trends, outcome and Molecular Events in Oncogenes
Thomas E. Carey, PhD Professor of Otolaryngology/Head & Neck Surgery Professor of Pharmacology University of Michigan Michigan Medicine.
Somos Valdecilla
Hodgkin's Lymphoma Treatment | Dr. Ajay Gopal Describes the Therapy
Dr. Ajay Gopal discusses the treatment of Hodgkin's lymphoma and describes the course of therapy beginning with the first patient meeting. Learn more at ...
Seattle Cancer Care Alliance
How I approach the initial treatment of mantle cell lymphoma
Earn CME credit for a related activity: https://www.naccme.com/oln In this presentation from Lymphoma & Myeloma 2018, Dr. Jonathan Cohen discusses his ...
ImedexCME
Debate 10: What do we do after FOLFIRINOX? - Gemcitabine is Standard
Filmed on location in New York during the Great Debates and Updates in GI Malignancies 2015, this webcast is part of a series that provides educational ...
ImedexCME
Follicular Lymphoma Debate: Watch and Wait or Treat Immediately?
Earn CME: https://www.naccme.com/program/19-lm-12 In this webcast from the 'Moving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma' ...
ImedexCME
Restricting Use of iron to Tumors Might be Novel Cancer Treatment-Mayo Clinic
Researchers at Mayo Clinic report in the July 2010 issue of The Journal of Clinical Investigation the first demonstration of a molecular mechanism by which a ...
Mayo Clinic
Advancements in the Treatment of Blood Cancers | Herbert Eradat, MD - Closer to a Cure Series
UCLA oncologist Herbert Eradat, MD, MS talks about the recent advances in the treatment of blood cancers. Learn more: www.uclahealth.org/closer-to-a-cure.
UCLA Health
Highlights from ASH 2016: deintensifying chemotherapy for children with ALL
Anthony Moorman, PhD from Newcastle University, Newcastle, UK provides highlights from the the 2016 American Society of Hematology (ASH) Annual ...
VJHemOnc – Video Journal of Hematological Oncology
ASCO COVID 19 and Cancer Presscast
For more information, visit http://www.asco.org/
ASCOcancer